Author: Haagmans, Bart L.; Osterhaus, Albert D.M.E.
Title: Coronaviruses and their therapy Cord-id: j0496jb7 Document date: 2006_6_19
ID: j0496jb7
Snippet: Coronaviruses may cause respiratory, enteric and central nervous system diseases in many species, including humans. Until recently, the relatively low burden of disease in humans caused by few of these viruses hampered development of coronavirus specific therapeutics. However, the emergence of severe acute respiratory syndrome coronavirus (SARS-CoV) has prompted the discovery of such drugs. Subsequent studies in animal models demonstrated the efficacy of SARS-CoV specific monoclonal antibodies,
Document: Coronaviruses may cause respiratory, enteric and central nervous system diseases in many species, including humans. Until recently, the relatively low burden of disease in humans caused by few of these viruses hampered development of coronavirus specific therapeutics. However, the emergence of severe acute respiratory syndrome coronavirus (SARS-CoV) has prompted the discovery of such drugs. Subsequent studies in animal models demonstrated the efficacy of SARS-CoV specific monoclonal antibodies, pegylated-interferon-α and siRNAs against SARS-CoV. Furthermore, several antivirals shown to be effective against other viruses were tested in vitro. Because of availability and shown efficacy, the use of interferons may be considered should SARS-CoV or a related coronavirus (re)-emerge. The more recent design of wide-spectrum inhibitors targeting the coronavirus main proteases may lead to the discovery of new antivirals against multiple coronavirus induced diseases.
Search related documents:
Co phrase search for related documents- abolished shedding and acute respiratory distress syndrome: 1
- action unknown mechanism and acute sars cov respiratory syndrome coronavirus: 1
- active compound and acute respiratory distress syndrome: 1, 2
- active compound and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- active passive and acute respiratory distress syndrome: 1, 2, 3
- active passive and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9
- active passive immunization and acute sars cov respiratory syndrome coronavirus: 1, 2
- acute phase and lopinavir ritonavir: 1, 2, 3, 4, 5
- acute phase and lopinavir ritonavir combination: 1
- acute respiratory distress syndrome and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory distress syndrome and lopinavir ritonavir addition: 1
- acute respiratory distress syndrome and lopinavir ritonavir combination: 1, 2, 3, 4, 5, 6, 7
- acute respiratory distress syndrome and lopinavir ritonavir group: 1
- acute respiratory distress syndrome and lopinavir ritonavir receive: 1
- acute respiratory distress syndrome and lopinavir ritonavir treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
- acute sars cov respiratory syndrome coronavirus and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute sars cov respiratory syndrome coronavirus and lopinavir ritonavir addition: 1, 2
- acute sars cov respiratory syndrome coronavirus and lopinavir ritonavir combination: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- acute sars cov respiratory syndrome coronavirus and lopinavir ritonavir group: 1, 2
Co phrase search for related documents, hyperlinks ordered by date